News

Explore Bigbank AS's Latest Offering of AT1 Bonds

Explore Bigbank AS's Latest Offering of AT1 Bonds

Bigbank AS Introduces Additional Tier 1 Bonds

Bigbank AS is embarking on an exciting journey by conducting a private placement of Additional Tier 1 Temporary Write-Down Notes, commonly known as AT1 bonds. These financial instruments are unique due to their complexity and are tailored specifically for selected investors, steering clear of general public offerings. This strategy targets a niche market, ensuring the bonds reach the right hands.

Investment Details and Key Features

The subscription period for the AT1 bonds is set from March 13 to March 18. A maximum of 300 bonds will be issued, with each bond carrying a nominal value of EUR 10,000. Bigbank AS possesses the flexibility to adjust the issue volume based on market conditions. Investors should note that these bonds come with an attractive annual interest rate of 9%, which will be paid quarterly, alongside a minimum investment threshold of EUR 20,000.

Understanding AT1 Bonds

AT1 bonds represent perpetual and unsecured debt instruments, offering a unique investment avenue. Additionally, contingent upon receiving the necessary approval from the Financial Supervision Authority, Bigbank AS holds the discretion to redeem these bonds, either in part or in full, five years following their issuance. This feature provides a layer of flexibility for the bank and its investors.

Bigbank’s Financial Health and Position

With an impressive history spanning over three decades, Bigbank AS stands as a pillar within the banking sector. As of the latest reports, their total assets amount to €2.9 billion, and their equity stands at €275 million. Operating across nine countries, Bigbank proudly serves over 169,000 active customers with a dedicated team of over 500 employees. The bank’s long-term deposit rating from Moody's is Ba1, showcasing its strong position in the industry, alongside a baseline credit assessment and an adjusted BCA rating of Ba2.

Why Choose Bigbank AS?

Choosing to invest with Bigbank AS is a testament to aligning with a bank that combines experience and stability. Their consistent growth and strategic positioning make them an appealing option for investors looking to diversify their portfolios with AT1 bonds. Investors can have confidence in the bank’s sound financial practices and market understanding.

Contact Information

For inquiries regarding the AT1 bonds, interested parties can reach Argo Kiltsmann, a member of the Management Board. He can be contacted via telephone at +372 53 930 833 or through email at Argo.Kiltsmann@bigbank.ee. The official website, which provides further insights, is www.bigbank.ee.

Frequently Asked Questions

What are Additional Tier 1 bonds?

AT1 bonds are perpetual unsecured debt instruments that offer higher yields and are primarily targeted at institutional investors.

What is the interest rate on Bigbank AS AT1 bonds?

These bonds come with a competitive annual interest rate of 9%, payable quarterly.

Who can invest in these bonds?

This offering is exclusively targeted at selected investors, excluding the general public.

How long is the subscription period?

The subscription for the AT1 bonds is open from March 13 until March 18.

What is Bigbank AS's financial standing?

As of now, Bigbank AS has total assets of €2.9 billion and equity of €275 million, holding a strong position in the banking sector.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

SystImmune's Data on Iza-bren Show Promise for Lung Cancer

Updated Category News Views 7

Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...

Continue Reading
Nocpix Unveils ACE 2 Thermal Riflescope Lineup

Updated Category News Views 5

ACE 2: A Thermal Riflescope That Promises More Let’s dive right into the nitty-gritty of Nocpix’s latest move. On September 12, they launched the ACE 2 Series—the next-gen beast of their flagship thermal riflescope lineup. A step up from the original ACE, this series aims to redefine what hunters can expect from a riflescope, introducing three models: ACE 2 S60R,...

Continue Reading
PathoSearch: A New Era in Pathology With Visual Search

Updated Category News Views 7

Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....

Continue Reading
Silk Road Maritime Extends Its Global Reach in 2026

Updated Category News Views 4

China-Europe Trade Ties Continue to Tighten You ever watch a cargo ship glide into port and think, "There's a piece of the future right there”? Well, that's the scene at Poland’s Gdansk Port, now officially etched into the Silk Road Maritime route. This ain't just a couple of extra boats cutting through choppy waters—it's a great leap forward for a strained global...

Continue Reading
Delhi Pushes Innovation Against Dryland Challenges

Updated Category News Views 5

Evolution of South-South Agricultural Cooperation Let's just say if there's a time to shine a spotlight on the arid lands of our world, it's now. The Global Drylands Congress 2026 in New Delhi put a sharp focus on scaling agricultural innovation across these thirsty regions. With climate change breathing down our necks, talking shop about food security isn't just for show...

Continue Reading
ARTiSTORY's Strategic Advance in Cultural IP Licensing

Updated Category News Views 5

Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...

Continue Reading
Countries Eye New Investment Paths at CIFIT 2026

Updated Category News Views 3

Global Investment Winds Shift at CIFIT In the thick of a world that's being turned on its head, you've got big shots from 129 countries and 30 international organizations talking shop at the 26th China International Fair for Investment and Trade (CIFIT) in Xiamen. Take your pick from the 48 of the world's top 50 GDP powerhouses rubbing shoulders there—this ain't your...

Continue Reading
IASLC Boosts Global Thoracic Cancer Collaboration

Updated Category News Views 3

Breaking Down Barriers in Thoracic Oncology Picture a world where financial walls don't block innovation and knowledge sharing in cancer treatment. The International Association for the Study of Lung Cancer (IASLC) is leading the charge here. They've just launched a new initiative offering complimentary full membership to qualified healthcare professionals in low- and...

Continue Reading

Top 5 Most Recently Viewed Articles

Unlocking Home Manufacturing: Profit Without Traditional Costs

Updated Category News Views 131

Turning a Passion into Profit Meet Damian, an entrepreneur who has tapped into the innovative world of home manufacturing, earning an impressive $40,000 monthly from his passion project. He has taken the leap into the manufacturing market by creating open-source MicroRacers right from his home. Rather than relying on expensive factories or hiring a full team, Damian has...

Continue Reading
HTeaO and poppi's Exciting New Beverage Collaboration

Updated Category News Views 796

HTeaO Partners with poppi for Unique Beverage Launch In an exciting development, HTeaO, a prominent franchise known for its delicious iced teas, has joined forces with poppi, the trendy prebiotic soda brand. Together, they are set to create a selection of extraordinary beverages that beautifully blend the flavors of fizzy sodas with freshly brewed teas, designed to...

Continue Reading
Empowering Women Entrepreneurs Through Block Advisors Grants

Updated Category News Views 346

Block Advisors Celebrates Women-Owned Businesses with Grants Block Advisors, a prominent name in supporting small businesses, recently revealed the six winners of its second annual Fund Her Future grant program. This initiative is dedicated to empowering women entrepreneurs, providing $100,000 in grants, which includes one grand prize of $50,000 and five additional...

Continue Reading
The Incredible Growth Journey of NVIDIA Investments Over a Decade

Updated Category News Views 296

NVIDIA's Spectacular Growth: A Decade of Investing NVIDIA has consistently shown its prowess in the stock market, significantly outpacing the market with an impressive 66.08% annualized return over the past ten years. The company's market capitalization stands at a staggering $4.44 trillion, showcasing its dominant position in the tech industry. The Power of Compound...

Continue Reading
Barclays Analysts Predict Google Share Rally with Remedies

Updated Category News Views 172

Potential Upside for Google Shares Amid Antitrust Remedies Barclays analysts have shared insights indicating that Google's proposed remedies could pave the way for substantial gains for Alphabet (NASDAQ: GOOGL) shares. These remedies are a response to the ongoing antitrust proceedings against the tech giant, which has significant implications for its financial future. The...

Continue Reading